154 related articles for article (PubMed ID: 38497469)
1. Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT.
Smith C; Berry JD; Scherzer R; de Lemos JA; Nambi V; Ballantyne CM; Kravitz RL; Killeen AA; Ix JH; Shlipak MG; Ascher SB
J Am Heart Assoc; 2024 Mar; 13(6):e032493. PubMed ID: 38497469
[TBL] [Abstract][Full Text] [Related]
2. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.
McEvoy JW; Chen Y; Rawlings A; Hoogeveen RC; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
J Am Coll Cardiol; 2016 Oct; 68(16):1713-1722. PubMed ID: 27590090
[TBL] [Abstract][Full Text] [Related]
3. Trends in Blood Pressure and High-Sensitivity Cardiac Troponin-T With Cardiovascular Disease: The Cardiovascular Health Study.
Tehrani DM; Fan W; Nambi V; Gardin J; Hirsch CH; Amsterdam E; deFilippi CR; Polonsky T; Wong ND
Am J Hypertens; 2019 Sep; 32(10):1013-1020. PubMed ID: 31232455
[TBL] [Abstract][Full Text] [Related]
4. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
Berry JD; Chen H; Nambi V; Ambrosius WT; Ascher SB; Shlipak MG; Ix JH; Gupta R; Killeen A; Toto RD; Kitzman DW; Ballantyne CM; de Lemos JA
Circulation; 2023 Jan; 147(4):310-323. PubMed ID: 36533535
[TBL] [Abstract][Full Text] [Related]
5. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT.
Ascher SB; Scherzer R; de Lemos JA; Estrella MM; Jotwani VK; Garimella PS; Bullen AL; Ambrosius WT; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
J Am Heart Assoc; 2022 Mar; 11(6):e023314. PubMed ID: 35243872
[TBL] [Abstract][Full Text] [Related]
6. High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT).
Jia X; Nambi V; Berry JD; Dalmacy D; Ascher SB; Taylor AA; Hoogeveen RC; de Lemos JA; Ballantyne CM
Clin Chem; 2024 Feb; 70(2):414-424. PubMed ID: 38084941
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular outcome and home blood pressure in relation to silent myocardial ischemia in a clinical population: The J-HOP study.
Shimizu H; Hoshide S; Kanegae H; Kario K
J Clin Hypertens (Greenwich); 2020 Dec; 22(12):2214-2220. PubMed ID: 33086426
[TBL] [Abstract][Full Text] [Related]
8. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
[TBL] [Abstract][Full Text] [Related]
9. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE.
Juraschek SP; Wang D; McEvoy JW; Harrap S; Harris K; Mancia G; Marre M; Neal B; Patel A; Poulter NR; Williams B; Chalmers J; Woodward M; Selvin E
Int J Cardiol; 2022 Jul; 358():103-109. PubMed ID: 35439582
[TBL] [Abstract][Full Text] [Related]
11. Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease.
Chang TI; Wei G; Boucher R; Kramer H; Chertow GM; Cheung AK; Greene T; Whelton PK; Beddhu S
Kidney360; 2020 May; 1(5):368-375. PubMed ID: 35369376
[TBL] [Abstract][Full Text] [Related]
12. High-Sensitivity Cardiac Troponin T and Risk of Hypertension.
McEvoy JW; Chen Y; Nambi V; Ballantyne CM; Sharrett AR; Appel LJ; Post WS; Blumenthal RS; Matsushita K; Selvin E
Circulation; 2015 Sep; 132(9):825-33. PubMed ID: 26152706
[TBL] [Abstract][Full Text] [Related]
13. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
14. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
15. Association of lower nighttime diastolic blood pressure and hypoxia with silent myocardial injury: The Japan Morning Surge-Home Blood Pressure study.
Kubota K; Hoshide S; Kario K
J Clin Hypertens (Greenwich); 2021 Feb; 23(2):272-280. PubMed ID: 33314712
[TBL] [Abstract][Full Text] [Related]
16. Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
Bansal S; Boucher R; Shen J; Wei G; Chertow GM; Whelton PK; Cushman WC; Cheung AK; Beddhu S;
Clin J Am Soc Nephrol; 2024 May; 19(5):620-627. PubMed ID: 38262377
[TBL] [Abstract][Full Text] [Related]
17. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
[TBL] [Abstract][Full Text] [Related]
18. Relationship between orthostatic blood pressure changes and intensive blood pressure management in patients with hypertension.
Pei J; Zhang H; Li Y; Yan J; Zheng K; Wang X; Zheng XL; Hu X
Heart; 2022 Dec; 109(2):111-118. PubMed ID: 36007937
[TBL] [Abstract][Full Text] [Related]
19. Association between high sensitivity cardiac troponin and mortality risk in the non-diabetic population: findings from the National Health and Nutrition Examination Survey.
Liu L; Cheng YT; Xu A; Cheung BMY
Cardiovasc Diabetol; 2023 Oct; 22(1):296. PubMed ID: 37904214
[TBL] [Abstract][Full Text] [Related]
20. Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.
Zanchin T; Räber L; Koskinas KC; Piccolo R; Jüni P; Pilgrim T; Stortecky S; Khattab AA; Wenaweser P; Bloechlinger S; Moschovitis A; Frenk A; Moro C; Meier B; Fiedler GM; Heg D; Windecker S
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
